Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-10-20-Speech-3-670"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101020.26.3-670"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
"Honourable Members, I should like to begin by thanking, even if he is not present, the honourable Member who tabled this question for his interest in this matter. It is true that neurodegenerative diseases, neurological development disorders and non-psychiatric brain diseases, of which epilepsy is one, are a major concern for many of our fellow citizens.
In accordance with Article 168 of the Treaty on the Functioning of the European Union, the Union shall encourage cooperation between the Member States in the field of public health and disease prevention. A horizontal approach is therefore taken at EU level, with the focus being on combating stigmatisation of and discrimination against people affected by neurodegenerative diseases, neurological development disorders and non-psychiatric brain diseases.
Hence, the Council invited the Member States, in its June 2003 conclusions on combating stigma and discrimination in relation to mental health, to give specific attention to the impact of stigma and discrimination related problems due to mental illness in all age groups, and to ensure that these problems are recognised, in this context, giving special attention to the reduction of risks of social exclusion.
In its conclusions of 3 June 2005 on Community action in the field of mental health, the Council invited the Member States to implement the declaration and action plan adopted by the European Ministerial Conference of the World Health Organisation on mental health, held in Helsinki in January 2005.
Finally, the Council is particularly committed to combating another illness that is part of the group of neurodegenerative diseases, neurological development disorders and non-psychiatric brain diseases, namely Alzheimer’s disease. I should mention in this connection the conclusions of 16 December 2008 on public health strategies to combat neurodegenerative diseases associated with ageing and, in particular, Alzheimer’s disease, and the conclusions of 3 December 2009 on joint programming of research in Europe, covering, in particular, the launch of the pilot joint programming initiative dedicated to the fight against neurodegenerative diseases and Alzheimer’s disease in particular."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples